The Prevention of Cisplatin-Induced Nephrotoxicity: A General Consensus Statement of a Group of Oncologist-Hematologists, Adult and Pediatric Nephrologists, Radiation Oncologists, Clinical Pathologists, Clinical Pharmacologists, and Renal Physiologists on Cisplatin Therapy in Cancer Patients

BACKGROUNDS: Most of the cancer patients with solid tumor are subjected to chemotherapy with cisplatin (CP) in clinic. However, the most side effect of CP is nephrotoxicity, which limits the treatment. The aim of study was to develop a general consensus statement for CP therapy in clinic to limit th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashrafi, Farzaneh, Mortazavi, Mojgan, Nematbakhsh, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980816/
https://www.ncbi.nlm.nih.gov/pubmed/35392316
http://dx.doi.org/10.4103/ijpvm.IJPVM_445_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980816/
https://www.ncbi.nlm.nih.gov/pubmed/35392316
http://dx.doi.org/10.4103/ijpvm.IJPVM_445_19

Ejemplares similares